Creative Medical Technology
CELZ
13 hedge funds and large institutions have $552K invested in Creative Medical Technology in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
510% more capital invested
Capital invested by funds: $90.4K → $552K (+$461K)
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
63% more funds holding
Funds holding: 8 → 13 (+5)
6.38% more ownership
Funds ownership: 1.42% → 7.8% (+6.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
+$76.3K |
| 2 |
VF
Virtu Financial
New York
|
+$76.2K |
| 3 |
Two Sigma Investments
New York
|
+$69.3K |
| 4 |
HF
HRT Financial
New York
|
+$61.4K |
| 5 |
Two Sigma Advisers
New York
|
+$54.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
-$23 |
| 2 |
ODG
O'Dell Group
Cincinnati,
Ohio
|
-$5 |
CELZ Hedge Fund Activity: Q1 2024 in Review
13 of the 6,957 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q1 2024, worth a combined $552K — up 510% from $90.4K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CELZ positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Aaron Wealth Advisors, opening a new position worth an estimated $76.3K. The largest seller was IFP Advisors, exiting entirely with an estimated $23 sold.
- 13 institutional investors held Creative Medical Technology (CELZ) as of Q1 2024, up from 8 in Q4 2023.
- Funds reported $552K of Creative Medical Technology stock for Q1 2024, up 510% quarter-over-quarter.
- 7 funds opened new Creative Medical Technology positions in Q1 2024 and 2 closed out, a net change of +5 holders.
- The largest Creative Medical Technology buyer in Q1 2024 was Aaron Wealth Advisors, an estimated $76.3K added.
- The largest Creative Medical Technology seller in Q1 2024 was IFP Advisors, an estimated $23 sold.
Based on aggregated 13F filings for Q1 2024.